Cargando…

PB2284: EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC ASPECT OF INDOLENT LYMPHOMAS IN TUNISIA

Detalles Bibliográficos
Autores principales:	Charef, Ons, Boukhriss, Sarra, Bnouni, Yasmine, Mlayah, Zaineb, Boufrikha, Wiem, Nader, Slama, Laatiri, Adnene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429781/ http://dx.doi.org/10.1097/01.HS9.0000975868.99369.1e

Ejemplares similares

PB2631: CLINICAL FEATURES, TREATMENTS AND OUTCOMES OF PRIMARY IMMUNE THROMBOCYTOPENIA IN ADULTS: A SINGLE CENTER RETROSPECTIVE STUDY FROM TUNISIA.
por: Bnouni, Yasmine, et al.
Publicado: (2023)

PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
por: Charef, Ons, et al.
Publicado: (2023)

PB1982: EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC FEATURES OF CHRONIC MYELOID LEUKEMIA: EXPERIENCE OF FATTOUMA BOURGUIBA HOSPITAL OF MONASTIR
por: Lakhel, Sana, et al.
Publicado: (2023)

PB2160: MULTIPLE MYELOMA IN THE ELDERLY: A MONOCENTRIC EXPERIENCE OF THE HEMATOLOGY DEPARTMENT OF MONASTIR (TUNISIA)
por: Inaam, Bizid, et al.
Publicado: (2023)

PB2563: IRON DEFICIENCY ANEMIA: A MONOCENTRIC EXPERIENCE OF THE HAEMATOLOGY DEPARTMENT OF MONASTIR, TUNISIA
por: Bouhoula, Donia, et al.
Publicado: (2023)

PB2354: DIFFUSE LARGE B CELL LYMPHOMA IN 65: DIAGNOSTIC, PROGNOSTIC, PROGRESSIVE AND THERAPEUTIC ASPECTS
por: Mlayah, Zaineb, et al.
Publicado: (2023)

PB1834: ACQUIRED FACTOR VII DEFICIENCY ASSOCIATED WITH ACUTE MYELOID LEUKEMIA
por: Hafsa, Haifa, et al.
Publicado: (2023)

PB2241: THE VASCULAR RISK OF ESSENTIAL THROMBOCYTHEMIA AND RELIABILITY OF THROMBOTIC RISK ASSESSMENT SCORES
por: Cheffai, Arij, et al.
Publicado: (2023)

PB2250: THE IMPACT OF JAK2V617F MUTATION POSITIVITY IN ESSENTIAL THROMBOCYTHEMIA:ABOUT 74 CASES.
por: Cheffai, Arij, et al.
Publicado: (2023)

Autoimmune hemolytic anemia complicating a chronic neutrophilic leukemia: A case report of a rare association
por: Rakez, Rim, et al.
Publicado: (2023)

PB1964: COMPARISON OF CLINICO-HEMATOLOGICAL PARAMETERS AND MOLECULAR AND CYTOGENETIC RESPONSE OF TWO BCR-ABL FUSION TRANSCRIPTS IN CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB
por: Baraa, Laabidi, et al.
Publicado: (2023)

PB2594: BACTEREMIA AND FEBRILE NEUTROPENIA IN PATIENTS TREATED FOR ACUTE LEUKEMIA
por: Inaam, Bizid, et al.
Publicado: (2023)

PB1963: A RARE CASE OF MULTIPLE SOLITARY PLASMOCYTOMA
por: Mlayah, Z., et al.
Publicado: (2022)

PB2258: MANAGEMENT OF FEBRILE NEUTROPENIA IN LEUKEMIC PATIENTS: A MONOCENTRIC STUDY
por: Boufrikha, W., et al.
Publicado: (2022)

Chronic-phase chronic myeloid leukemia: Incidence of BCR/ABL transcript and its correlation with presenting features, response to treatment, and survival
por: Laabidi, Baraa, et al.
Publicado: (2023)

PB2296: THE PROGNOSTIC ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATIO IN COVID-19 PATIENTS: A MONOCENTRIC STUDY
por: Boufrikha, W., et al.
Publicado: (2022)

PB2284: PROTECTION OF PATIENTS WITH HEMATOLOGIC MALIGNANCY FROM SEVERE INFECTION DURING PANDEMIA: ESTONIAN TWO CENTRES EXPERIENCE
por: Vaide, I., et al.
Publicado: (2022)

The diagnostic dilemma of idiopathic intracranial hypertension in a child with acute lymphoblastic leukemia: COVID-19 or cytosine arabinoside?
por: Rakez, Rim, et al.
Publicado: (2022)

PB1891: EARLY DEATH IN ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA
por: Koubaa, Asma, et al.
Publicado: (2023)

PB1819: CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA
por: kasser, O., et al.
Publicado: (2022)

PB1895: CHARACTERISTICS AND OUTCOME OF PEADIATRIC ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA
por: Koubaa, Asma, et al.
Publicado: (2023)

PB2320: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONG THE ELDERLY: A TUNISIAN MULTICENTER EXPERIENCE.
por: Zahra, Kmira, et al.
Publicado: (2023)

PB2650: ALLOANTIBODIES IN VON WILLEBRAND DISEASE: ABOUT 6 CASES IN SOUTHERN TUNISIA
por: Chalbaoui, Amal, et al.
Publicado: (2023)

PB2340: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONGPATIENTS AGED LESS THAN 60 YEARS: A TUNISIAN MULTICENTER EXPERIENCE.
por: Zahra, Kmira, et al.
Publicado: (2023)

PB1767: OUTCOME OF RELAPSED CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN THE SOUTH OF TUNISIA SINGLE CENTER EXPERIENCE
por: Siala, N., et al.
Publicado: (2022)

PB2526: UMBILICAL CORD BLOOD SCREENING FOR SICKLE CELL DISEASE: A PILOT STUDY IN THE NORTH OF TUNISIA
por: Ouragini, Houyem, et al.
Publicado: (2023)

PB1732: CLINICAL CHARACTERISTICS AND THERAPEUTIC RESULTS OF CHILDHOOD AND YOUNG ADULTS T - ACUTE LYMPHOBLASTIC LEUKEMIA IN SOUTH OF TUNISIA
por: Frikha, Imen, et al.
Publicado: (2023)

PB1875: TREATMENT OF YOUNGER PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN TUNISIA: FCR STILL STANDARD FOR FIRST-LINE THERAPY
por: Miled, W., et al.
Publicado: (2022)

PB2006: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH PLASMA CELL LEUKEMIA (PCL): A SINGLE-CENTER STUDY FROM TUNISIA
por: Fakhfakh, Y., et al.
Publicado: (2022)

PB1876: SIXTEEN YEARS OF EXPERIENCE WITH THE MRC-10 PROTOCOL FOR THE TREATMENT OF ADULT ACUTE MYELOID LEUKEMIA IN THE SOUTH OF TUNISIA
por: Siala, Nour, et al.
Publicado: (2023)

PB1758: TWENTY-ONE YEARS’ EXPERIENCE OF THE EORTC 58951 PROTOCOL FOR THE TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN THE SOUTH OF TUNISIA
por: Frikha, I., et al.
Publicado: (2022)

PB2368: THE PRE-EMPTIVE STRATEGY OF HEPATITIS B VIRAL REACTIVATION IN PATIENTS WITH MALIGNANT HEMOPATHIES RECEIVING IMMUNSUPPRESSIVE THERAPY IN TUNISIA
por: Wafa, Miled, et al.
Publicado: (2023)

PB1824: IMPACT OF DAY 15 BONE MARROW ASPIRATION ON PREDICTION OF COMPLETE REMISSION AND RELAPSE IN ACUTE MYELOID LEUKEMIA
por: Kharrat, R., et al.
Publicado: (2022)

PB2446: ALLOGENEIC STEM CELL TRANSPLANTATION WITH GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) PRIMED BONE MARROW: PROSPECTIVE STUDY OF THE NATIONAL BONE MARROW TRANSPLANT CENTER IN TUNISIA
por: Yosra Kanoun, Rimmel, et al.
Publicado: (2023)

PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA.
por: Yosra Kanoun, Rimmel, et al.
Publicado: (2023)

PB1726: HEARING STATUS OF SURVIVORS OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
por: Mahfouz, Asmaa, et al.
Publicado: (2023)

PB2560: LYSOSOMAL STORAGE DISEASES: GUACHER’S DISEASE AND NIEMANPICK ‘S DISEASES: STUDY OF CLINICAL, CYTOLOGICAL AND ENZYMATIC ASPECTS
por: Mohamed, Lina, et al.
Publicado: (2023)

PB2081: CYTOGENETICS OF MULTIPLE MYELOMA IN MOROCCO
por: Moutmir, Yasmine, et al.
Publicado: (2023)

PB2153: SURGICAL SPECIMENS OF INDOLENT AND AGGRESSIVE B-NHLS SHOW DIFFERENCES IN THEIR FLOW-CYTOMETRY PROFILE OF PLOIDY, PROLIFERATING FRACTION AND PROPORTION OF TUMOR-ASSOCIATED MYELOID AND T-CELL SUBSETS
por: Azoulay, D., et al.
Publicado: (2022)

PB2058: SCREENING FOR ANTINEUTROPHIL ANTIBODIES IN PATIENTS WITH SEVERE CHRONIC NEUTROPENIA AT ALEXANDRIA UNIVERSITY CHILDREN’S HOSPITAL
por: Werby, Ahmed, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nf32gm83nl0pi8cln3mnjan0vj